Repository logo
 
Publication

Toxicological Aspects of Iron Oxide Nanoparticles

dc.contributor.authorFernández-Bertólez, Natalia
dc.contributor.authorCosta, Carla
dc.contributor.authorBrandão, Fátima
dc.contributor.authorTeixeira, João Paulo
dc.contributor.authorPásaro, Eduardo
dc.contributor.authorValdiglesias, Vanessa
dc.contributor.authorLaffon, Blanca
dc.date.accessioned2023-04-17T14:24:25Z
dc.date.available2023-04-17T14:24:25Z
dc.date.issued2022-05-19
dc.descriptionPart of the book series: Advances in Experimental Medicine and Biology (AEMB, volume 1357)pt_PT
dc.description.abstractIron oxide nanoparticles (ION), with unique magnetic properties, have attracted huge scientific attention for a wide variety of uses, mostly in the biomedical field, due to their high biocompatibility, ability to cross biological membranes, appropriate surface architecture and easy conjugation with targeting ligands. Their current applications include diagnostic imaging, cell labelling, site-directed drug delivery and anticancer hyperthermia therapy. The ION surface may be modified by coating with different materials, aiming to stabilize the nanoparticles in different environments, to allow biomolecule binding favouring surface attachments with several molecules, and to prolong the recognition time by the immune system. Although the potential benefits of ION are considerable, and more and more ION are being manufactured to meet the demands of the rapidly proliferating field of nanomedicine, there is an urgent need to define their toxicological profile in order to avoid any potential health risks associated with their exposure and to reach optimal benefits of their use. The purpose of this chapter is to de-scribe the current knowledge on the ION toxicological features, addressing their structure and physicochemical characteristics, main exposure pathways and toxicokinetic aspects, interaction with cells, and their toxic effects, with special attention to those at the cellular and molecular level.pt_PT
dc.description.sponsorshipThe present work was supported by Xunta de Galicia (reference ED431B 2019/02), Ministerio de Ciencia e Innovación (PID2020-114908GA-I00), TOXI-NANO (SEM2021-A1), NeuroiNPact (SEM2021-B2), NanoBioBarriers (PTDC/MED-TOX/31162/2017) funded by Operational Program for Competitiveness and Internationalisation through European Regional Development Funds (FEDER/FNR) and through national funds by the Portuguese Foundation for Science and Technology (FCT), and NanoLegaTox (PTDC/SAU-PUB/29651/2017) project co-financed by COMPETE 2020, Portugal 2020 and European Union, through FEDER. Vanessa Valdiglesias was supported by Ministerio de Educación, Cultura y Deporte (reference BEAGAL18/00142), and Fátima Brandão by the Portuguese Foundation for Science and Technology (SFRH/BD/101060/2014). Authors would also like to acknowledge COST Action CA17140 “Cancer nanomedicine – from the bench to the bedside (NANO2CLINIC)”.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationIn: Louro H, Silva MJb(eds). Nanotoxicology in Safety Assessment of Nanomaterials. Adv Exp Med Biol. 2022;1357:303-350. doi: 10.1007/978-3-030-88071-2_13pt_PT
dc.identifier.doi10.1007/978-3-030-88071-2_13pt_PT
dc.identifier.isbn978-3-030-88071-2
dc.identifier.urihttp://hdl.handle.net/10400.18/8612
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherSpringerpt_PT
dc.relationEstablishing grouping strategies according to toxicity and biological effects for silica based manufactured nanomaterials
dc.relation.publisherversionhttps://link.springer.com/chapter/10.1007/978-3-030-88071-2_13pt_PT
dc.subjectIron Oxide Nanoparticlespt_PT
dc.subjectPhysicochemical Propertiespt_PT
dc.subjectCellular Uptakept_PT
dc.subjectCytotoxicitypt_PT
dc.subjectGenotoxicitypt_PT
dc.subjectNanotoxicologypt_PT
dc.subjectNanomaterialspt_PT
dc.subjectGenotoxicidade Ambientalpt_PT
dc.titleToxicological Aspects of Iron Oxide Nanoparticlespt_PT
dc.typebook part
dspace.entity.typePublication
oaire.awardTitleEstablishing grouping strategies according to toxicity and biological effects for silica based manufactured nanomaterials
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/9471 - RIDTI/PTDC%2FMED-TOX%2F31162%2F2017/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/9471 - RIDTI/PTDC%2FSAU-PUB%2F29651%2F2017/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/OE/SFRH%2FBD%2F101060%2F2014/PT
oaire.citation.endPage350pt_PT
oaire.citation.issueIn: Louro, H., Silva, M.J. (eds) Nanotoxicology in Safety Assessment of Nanomaterials. Advances in Experimental Medicine and Biology, vol 1357. Springer, Cham. https://doi.org/10.1007/978-3-030-88071-2_13pt_PT
oaire.citation.startPage303pt_PT
oaire.citation.titleAdvances in Experimental Medicine and Biologypt_PT
oaire.citation.volume1357pt_PT
oaire.fundingStream9471 - RIDTI
oaire.fundingStream9471 - RIDTI
oaire.fundingStreamOE
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
rcaap.embargofctAcesso de acordo com política editorial da publicaçãopt_PT
rcaap.rightsembargoedAccesspt_PT
rcaap.typebookPartpt_PT
relation.isProjectOfPublication1370de00-d228-47a7-8aed-320831dc4dcd
relation.isProjectOfPublication9f23e866-c585-4ebc-af90-ee03cf2d2655
relation.isProjectOfPublication8bcb6d0f-fda0-470a-906d-c67c257beedb
relation.isProjectOfPublication.latestForDiscovery8bcb6d0f-fda0-470a-906d-c67c257beedb

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Nanotoxicology in safety assessment of nanomaterials.pdf
Size:
1.72 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: